Use of Sodium Stibogluconate as a Treatment for Leishmaniasis

NCT00657618 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

77

Enrollment

FED

Sponsor class

Conditions

Leishmaniasis

Interventions

DRUG: Sodium Stibogluconate (SSG)

Sponsor

U.S. Army Medical Research and Development Command

Collaborators

[object Object]